Publications
199
Citations
7,350
Est. group size
~7
Recurring co-author estimate
Active years
51
Publishing since 1976
Typically publishes in teams of ~9 · 8% small-team papers (≤3 authors) · across 20 venues
- Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis
BMJ Open · 2026
- 1929-P: Assessing Glycemic Variability by Continuous Glucose Monitoring: Implications for Prediabetes Subtypes and Potential Cardiovascular Risk
Diabetes · 2026
- Role of the kidney in glucose homeostasis: the basis for pharmacotherapy and prevention of cardiorenal complications in diabetes
Kidney International · 2026
- Changes in β-Cell Function and Insulin Sensitivity During Treatment With Dapagliflozin Alone or in Combination With Exenatide in Type 2 Diabetes
Diabetes Care · 2025
- 162-OR: Beta-Cell Preservation with Early Oral Antidiabetic Medications in Prediabetes (PreDM)
Diabetes · 2025
- Changes in β-Cell Function and Insulin Sensitivity During Treatment With Dapagliflozin Alone or in Combination With Exenatide in Type 2 Diabetes
2025
- Changes in β-Cell Function and Insulin Sensitivity During Treatment With Dapagliflozin Alone or in Combination With Exenatide in Type 2 Diabetes
2025
- Effect of weight-maintaining ketogenic diet on glycemic control and insulin sensitivity in obese T2D subjects
BMJ Open Diabetes Research & Care · 2024
- Effect of Hyperketonemia on Myocardial Function in Patients With Heart Failure and Type 2 Diabetes
Diabetes · 2024
- Effect of dapagliflozin on renal haemodynamics in hyperfiltering <scp>T2D</scp> patients
Diabetes Obesity and Metabolism · 2024
- Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects
Diabetes · 2024
- Mesenteric Visceral Lipectomy Improves Glucose Tolerance in Patients With Type 2 Diabetes: A Pilot Study
The Journal of Clinical Endocrinology & Metabolism · 2024
- Current Risk Management Strategies in Type 2 Diabetes
ASEAN Journal of Psychiatry · 2024
- Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2DM and NGT Subjects
2024
- Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2DM and NGT Subjects
2024
- Diabetes×39
- Diabetes Care×22
- Diabetes Obesity and Metabolism×5
- The Journal of Clinical Endocrinology & Metabolism×4
- JAMA Internal Medicine×2
- Curtis Triplitt
Medicine · University of Michigan
- Robert R. Henry
Medicine · University of Michigan
- C. Lovell
Medicine · University of Michigan
- Kieren J. Mather
Medicine · Indiana University
- C. Hazlett
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile